CST1 and atrial fibrillation: We next measured total cellular GSH in low-CST1 (LoVo) and high-CST1 (HT-29) cells and found that AF treatment led to a greater increase in cellular GSH levels in high-CST1 cells compared to that in low-CST1 cells (Figure 6b).